SELLAS Life Sciences Group, Inc. (SLS)
7.76
-0.22
(-2.76%)
USD |
NASDAQ |
Jun 09, 14:33
SELLAS Life Sciences Group SG&A Expense (Quarterly) : 4.123M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Savara, Inc. | 15.57M |
| Marker Therapeutics, Inc. | 1.230M |
| Rezolute, Inc. | 5.954M |
| KalVista Pharmaceuticals, Inc. | 48.80M |
| BeyondSpring, Inc. | 1.156M |